top of page

HEK293 ISRE-Luciferase Reporter Cell Line

Item
Cat#
Price

Stable Cell Line

SNB-SP-0009

$19,80

Compound Test Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The ISRE signaling pathway is a key mechanism through which cells respond to interferons (IFNs) and establish an antiviral state. When type I interferons (e.g., IFNα/β) bind to cell surface receptors, they activate JAK kinases, leading to the phosphorylation of STAT proteins. These form dimers that translocate into the nucleus and specifically bind to the "Interferon-Sensitive Response Element" (ISRE) in the promoter regions of target genes, initiating the transcription of antiviral and immunoregulatory genes. Based on this principle, the engineered HEK293 ISRE reporter cell line stably integrates a firefly luciferase reporter gene controlled by ISRE sequences, enabling sensitive monitoring of JAK/STAT pathway activity. It has been validated for its response to IFNα stimulation and treatment with JAK inhibitors, and is widely used for antiviral drug screening and research into immune modulation mechanisms. 

 

Screeningbio’s HEK293/ISRE/Luciferase reporter gene cell line stable transfected with ISRE response element and luciferase gene. Upon stimulated, ISRE pathway was activated and induce luciferase expression.


Product Specifications

Target Type

Signal Pathway

Species

Human

HGNC Symbol


Accession Number


Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data

HEK293/ISRE/Luciferase Agonist Assay. HEK293/ISRE/Luciferase reporter cells were treated with IFNα. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/ISRE/Luciferase Agonist Assay. HEK293/ISRE/Luciferase reporter cells were treated with IFNα. The assay was run based on Promega ONE-GLOTM Luciferase Assay System. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.



Target Background


The ISRE signaling pathway is a key mechanism through which cells respond to interferons (IFNs) and establish an antiviral state. When type I interferons (e.g., IFNα/β) bind to cell surface receptors, they activate JAK kinases, leading to the phosphorylation of STAT proteins. These form dimers that translocate into the nucleus and specifically bind to the "Interferon-Sensitive Response Element" (ISRE) in the promoter regions of target genes, initiating the transcription of antiviral and immunoregulatory genes. Based on this principle, the engineered HEK293 ISRE reporter cell line stably integrates a firefly luciferase reporter gene controlled by ISRE sequences, enabling sensitive monitoring of JAK/STAT pathway activity. It has been validated for its response to IFNα stimulation and treatment with JAK inhibitors, and is widely used for antiviral drug screening and research into immune modulation mechanisms. 


Product Documentation



Related Products


bottom of page